Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
0.326
-0.021 (-5.94%)
At close: Dec 30, 2024, 4:00 PM
0.340
+0.014 (4.17%)
Pre-market: Dec 31, 2024, 4:44 AM EST
Enveric Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 3 | 4 | 29 | 793 | - | |
| Market Cap Growth | -18.58% | -30.19% | -85.19% | -96.32% | - | - | |
| Enterprise Value | 0 | -1 | -16 | 8 | 795 | - | |
| Last Close Price | 0.33 | 1.30 | 2.08 | 46.50 | 213.00 | - | |
| PB Ratio | 0.74 | 1.54 | 0.28 | 1.31 | 232.13 | - | |
| P/TBV Ratio | 1.09 | 1.73 | 0.30 | 2.12 | 506.57 | - | |
| Debt / Equity Ratio | - | - | 0.00 | 0.01 | - | -0.41 | |
| Quick Ratio | 3.73 | 1.07 | 4.44 | 8.33 | 2.32 | 0.02 | |
| Current Ratio | 5.17 | 1.53 | 4.61 | 8.51 | 3.35 | 0.06 | |
| Return on Equity (ROE) | -308.65% | -197.47% | -97.57% | -380.82% | -855.92% | - | |
| Return on Assets (ROA) | -96.88% | -86.20% | -53.92% | -102.60% | -166.96% | -1183.53% | |
| Return on Capital (ROIC) | -173.07% | -116.97% | -65.49% | -122.09% | -299.51% | - | |
| Earnings Yield | -303.64% | -573.01% | -427.30% | -167.81% | -0.87% | - | |
| FCF Yield | -251.56% | -467.23% | -410.17% | -39.91% | -0.49% | - | |
| Buyback Yield / Dilution | -167.86% | -49.31% | -206.13% | -310.48% | -8.82% | 6.45% | |
| Total Shareholder Return | -167.86% | -49.31% | -206.13% | -310.48% | -8.82% | 6.45% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.